Rational use of antibiotics in the context of China's health system reform

The BMJ

Volumn 365, Issue , 2019, Pages

  He, Ping ^a   Sun, Qiang ^b   Shi, Lizheng ^c   Meng, Qingyue ^a  

^a PEKING UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c TULANE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

CHINA; DRUG UTILIZATION REVIEW; ECONOMICS; GOVERNMENT; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; MOTIVATION; PRACTICE GUIDELINE; PRESCRIPTION; STATISTICS AND NUMERICAL DATA;

ANTI-BACTERIAL AGENTS; CHINA; DRUG PRESCRIPTIONS; DRUG UTILIZATION REVIEW; GOVERNMENT PROGRAMS; HEALTH CARE REFORM; HEALTH EXPENDITURES; HUMANS; MOTIVATION; PRACTICE GUIDELINES AS TOPIC;

EID: 85067660017     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.l4016     Document Type: Article

References (33)

1. Cui D, Liu X, Hawkey P, et al. Use of and microbial resistance to antibiotics in China: a path to reducing antimicrobial resistance. J Int Med Res 2017;45:1768-78. doi:10.1177/0300060516686230
2. Lu Y, Hernandez P, Abegunde D, et al. The world medicines situation 2011. Medicine expenditures. World Health Organization, 2011.
3. Holloway K, Van Dijk L. The world medicines situation 2011. Rational use of medicines. World Health Organization, 2011.
4. Mao W, Vu H, Xie Z, Chen W, Tang S. Systematic review on irrational use of medicines in China and Vietnam. PLoS One 2015;10:e0117710. doi:10.1371/journal.pone.0117710
5. Yin X, Song F, Gong Y, et al. A systematic review of antibiotic utilization in China. J Antimicrob Chemother 2013;68:2445-52. doi:10.1093/jac/dkt223
6. Wang M. Antimicrobial resistance in China: challenges and actions. Clin Infect Dis 2018;67(suppl-2):S127. doi:10.1093/cid/ciy702
7. Mao W, Chen W. The zero mark-up policy for essential medicines at primary level facilities. World Health Organization, 2015.
8. Liu GG, Vortherms SA, Hong X. China's health reform update. Annu Rev Public Health 2017;38:431-48. doi:10.1146/annurev-publhealth-031816-044247
9. Yang C, Shen Q, Cai W, et al. Impact of the zeromarkup drug policy on hospitalisation expenditure in western rural China: an interrupted time series analysis. Trop Med Int Health 2017;22:180-6. doi:10.1111/tmi.12817
10. Sun Q, Santoro MA, Meng Q, Liu C, Eggleston K. Pharmaceutical policy in China. Health Aff (Millwood) 2008;27:1042-50. doi:10.1377/hlthaff.27.4.1042
11. World Health Organization. Antimicrobial resistance: global report on surveillance 2014. WHO, 2014.
12. Meng Q, Mills A, Han Q. What can we learn from China's health system reform. BMJ 2019;365:l2349. doi:10.1136/bmj.l2349
13. Commission NHaFP. Status report on antimicrobial and antimicrobial resistance in China. Beijing Union Medical University Press, 2018.
14. China MoHo. National special rectification activities program of clinical use of antibiotics (2011) 2011. http://www.moh.gov.cn/mohyzs/s3586/201104/51376.shtml.
15. Xiao Y, Li L. Legislation of clinical antibiotic use in China. Lancet Infect Dis 2013;13:189-91. doi:10.1016/S1473-3099(13)70011-2
16. Dellit TH, Owens RC, McGowan JEJr, et al, Infectious Diseases Society of America, Society for Healthcare Epidemiology of America. Guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007;44:159-77. doi:10.1086/510393
17. Yin J, Li Q, Sun Q. Antibiotic consumption in Shandong Province, China: an analysis of provincial pharmaceutical centralized bidding procurement data at public healthcare institutions, 2012-16. J Antimicrob Chemother 2018;73:814-20. doi:10.1093/jac/dkx469
18. Xiao Y. Antimicrobial stewardship in China: systems, actions and future strategies. Clin Infect Dis 2018;67(suppl-2):S135-41. doi:10.1093/cid/ciy641
19. Fu H, Li L, Yip W. Intended and unintended impacts of price changes for drugs and medical services: Evidence from China. Soc Sci Med 2018;211:114-22. doi:10.1016/j.socscimed.2018.06.007
20. Yin J, Wu C, Wei X, Sun Q. Antibiotic expenditure by public healthcare institutions in Shandong Province in China, 2012-2016. Frontiers in Pharmacology 2018;9:1396. doi:10.3389/fphar.2018.01396
21. Qu X, Yin C, Sun X, et al. Consumption of antibiotics in Chinese public general tertiary hospitals (2011-2014): Trends, pattern changes and regional differences. PLoS One 2018;13:e0196668. doi:10.1371/journal.pone.0196668
22. Bao L, Peng R, Wang Y, et al. Significant reduction of antibiotic consumption and patients' costs after an action plan in China, 2010-2014. PLoS One 2015;10:e0118868. doi:10.1371/journal. pone.0118868
23. China NHaFPCotPsRo. The administration on the clinical use of antimicrobial agents and the status quo of antimicrobial resistance in China. Beijing Union Medical University Press, 2016.
24. Yang L, Liu C, Ferrier JA, Zhou W, Zhang X. The impact of the National Essential Medicines Policy on prescribing behaviours in primary care facilities in Hubei province of China. Health Policy and Planning 2013;28:750-60. doi:10.1093/heapol/czs116
25. Chen M, Wang L, Chen W, Zhang L, Jiang H, Mao W. Does economic incentive matter for rational use of medicine? China's experience from the essential medicines program. Pharmacoeconomics 2014;32:245-55. doi:10.1007/s40273-013-0068-z
26. Wei X, Yin J, Walley JD, et al. Impact of China's essential medicines scheme and zero-markup policy on antibiotic prescriptions in county hospitals: a mixed methods study. Trop Med Int Health 2017;22:1166-74. doi:10.1111/tmi.12922
27. Xie X, Jin X, Zhang L, et al. Trends analysis for drug utilization in county public hospitals: a sample study of the pilot area of health care reform in China. BMC Health Services Research 2018;18:812. doi:10.1186/s12913-018-3614-8
28. Tang Y, Liu C, Liu J, Zhang X, Zuo K. Effects of county public hospital reform on procurement costs and volume of antibiotics: a quasinatural experiment in Hubei Province, China. Pharmacoeconomics 2018;36:995-1004. doi:10.1007/s40273-018-0654-1
29. Ma X, Hong W, Li Y, Shi L, Liu X. Realigning the incentive system for China's primary healthcare providers. BMJ 2019;365:l2406. doi:10.1136/bmj.l2406
30. Xue H, Shi Y, Huang L, et al. Diagnostic ability and inappropriate antibiotic prescriptions: a quasiexperimental study of primary care providers in rural China. J Antimicrob Chemother 2019;74:256-63. doi:10.1093/jac/dky390
31. Fletcher-Lartey S, Yee M, Gaarslev C, Khan R. Why do general practitioners prescribe antibiotics for upper respiratory tract infections to meet patient expectations: a mixed methods study. BMJ Open 2016;6:e012244. doi:10.1136/bmjopen-2016-012244
32. Sun X, Jackson S, Carmichael GA, Sleigh AC. Prescribing behaviour of village doctors under China's New Cooperative Medical Scheme. Soc Sci Med 2009;68:1775-9. doi:10.1016/j. socscimed.2009.02.043
33. World Health Organization. Promoting rational use of medicines: core components. 2002. http://apps.who.int/medicinedocs/pdf/h3011e/h3011e.pdf.